530207 — Brawn Biotech Balance Sheet
0.000.00%
- IN₹62.41m
- IN₹48.44m
- IN₹134.65m
- 13
- 38
- 69
- 31
Annual balance sheet for Brawn Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 15.7 | 15.2 | 14 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 53.3 | 39 | 34.3 |
| Total Inventory | |||
| Total Other Current Assets | |||
| Total Current Assets | 134 | 131 | 175 |
| Net Property, Plant And Equipment | 3.72 | 3.33 | 4.6 |
| Long Term Notes Receivable | |||
| Other Long Term Assets | |||
| Total Assets | 145 | 146 | 205 |
| Accounts Payable | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 80.5 | 65.1 | 93.3 |
| Long Term Debt | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 82.2 | 95.2 | 171 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Total Equity | 63.1 | 50.7 | 33.6 |
| Total Liabilities & Shareholders' Equity | 145 | 146 | 205 |
| Total Common Shares Outstanding |